Global Infliximab and biosimilar Market Research Report 2019


27-03-2019 / Healthcare / 98

Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.

The global Infliximab and biosimilar market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Infliximab and biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Infliximab and biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Janssen Biotech
Merck and Co.
Pfizer
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Infliximab
infliximab-dyyb
infliximab-abda

Segment by Application
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Plaque Psoriasis


End of Summary


Table of Contents

Executive Summary
1 Infliximab and biosimilar Market Overview
1.1 Product Overview and Scope of Infliximab and biosimilar
1.2 Infliximab and biosimilar Segment by Type
1.2.1 Global Infliximab and biosimilar Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Infliximab
1.2.3 infliximab-dyyb
1.2.4 infliximab-abda
1.3 Infliximab and biosimilar Segment by Application
1.3.1 Infliximab and biosimilar Consumption Comparison by Application (2014-2025)
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Rheumatoid Arthritis
1.3.6 Ankylosing Spondylitis
1.3.7 Psoriatic Arthritis
1.3.8 Plaque Psoriasis
1.4 Global Infliximab and biosimilar Market by Region
1.4.1 Global Infliximab and biosimilar Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Infliximab and biosimilar Market Size
1.5.1 Global Infliximab and biosimilar Revenue (2014-2025)
1.5.2 Global Infliximab and biosimilar Production (2014-2025)

2 Global Infliximab and biosimilar Market Competition by Manufacturers
2.1 Global Infliximab and biosimilar Production Market Share by Manufacturers (2014-2019)
2.2 Global Infliximab and biosimilar Revenue Share by Manufacturers (2014-2019)
2.3 Global Infliximab and biosimilar Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Infliximab and biosimilar Production Sites, Area Served, Product Types
2.5 Infliximab and biosimilar Market Competitive Situation and Trends
2.5.1 Infliximab and biosimilar Market Concentration Rate
2.5.2 Infliximab and biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Infliximab and biosimilar Production Market Share by Regions
3.1 Global Infliximab and biosimilar Production Market Share by Regions
3.2 Global Infliximab and biosimilar Revenue Market Share by Regions (2014-2019)
3.3 Global Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Infliximab and biosimilar Production
3.4.1 North America Infliximab and biosimilar Production Growth Rate (2014-2019)
3.4.2 North America Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Infliximab and biosimilar Production
3.5.1 Europe Infliximab and biosimilar Production Growth Rate (2014-2019)
3.5.2 Europe Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Infliximab and biosimilar Production (2014-2019)
3.6.1 China Infliximab and biosimilar Production Growth Rate (2014-2019)
3.6.2 China Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Infliximab and biosimilar Production (2014-2019)
3.7.1 Japan Infliximab and biosimilar Production Growth Rate (2014-2019)
3.7.2 Japan Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Infliximab and biosimilar Consumption by Regions
4.1 Global Infliximab and biosimilar Consumption by Regions
4.2 North America Infliximab and biosimilar Consumption (2014-2019)
4.3 Europe Infliximab and biosimilar Consumption (2014-2019)
4.4 China Infliximab and biosimilar Consumption (2014-2019)
4.5 Japan Infliximab and biosimilar Consumption (2014-2019)

5 Global Infliximab and biosimilar Production, Revenue, Price Trend by Type
5.1 Global Infliximab and biosimilar Production Market Share by Type (2014-2019)
5.2 Global Infliximab and biosimilar Revenue Market Share by Type (2014-2019)
5.3 Global Infliximab and biosimilar Price by Type (2014-2019)
5.4 Global Infliximab and biosimilar Production Growth by Type (2014-2019)

6 Global Infliximab and biosimilar Market Analysis by Applications
6.1 Global Infliximab and biosimilar Consumption Market Share by Application (2014-2019)
6.2 Global Infliximab and biosimilar Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Infliximab and biosimilar Business
7.1 Janssen Biotech
7.1.1 Janssen Biotech Infliximab and biosimilar Production Sites and Area Served
7.1.2 Infliximab and biosimilar Product Introduction, Application and Specification
7.1.3 Janssen Biotech Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Merck and Co.
7.2.1 Merck and Co. Infliximab and biosimilar Production Sites and Area Served
7.2.2 Infliximab and biosimilar Product Introduction, Application and Specification
7.2.3 Merck and Co. Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Pfizer
7.3.1 Pfizer Infliximab and biosimilar Production Sites and Area Served
7.3.2 Infliximab and biosimilar Product Introduction, Application and Specification
7.3.3 Pfizer Infliximab and biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served

8 Infliximab and biosimilar Manufacturing Cost Analysis
8.1 Infliximab and biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Infliximab and biosimilar
8.4 Infliximab and biosimilar Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Infliximab and biosimilar Distributors List
9.3 Infliximab and biosimilar Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Infliximab and biosimilar Market Forecast
11.1 Global Infliximab and biosimilar Production, Revenue Forecast
11.1.1 Global Infliximab and biosimilar Production Growth Rate Forecast (2019-2025)
11.1.2 Global Infliximab and biosimilar Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Infliximab and biosimilar Price and Trend Forecast (2019-2025)
11.2 Global Infliximab and biosimilar Production Forecast by Regions (2019-2025)
11.2.1 North America Infliximab and biosimilar Production, Revenue Forecast (2019-2025)
11.2.2 Europe Infliximab and biosimilar Production, Revenue Forecast (2019-2025)
11.2.3 China Infliximab and biosimilar Production, Revenue Forecast (2019-2025)
11.2.4 Japan Infliximab and biosimilar Production, Revenue Forecast (2019-2025)
11.3 Global Infliximab and biosimilar Consumption Forecast by Regions (2019-2025)
11.3.1 North America Infliximab and biosimilar Consumption Forecast (2019-2025)
11.3.2 Europe Infliximab and biosimilar Consumption Forecast (2019-2025)
11.3.3 China Infliximab and biosimilar Consumption Forecast (2019-2025)
11.3.4 Japan Infliximab and biosimilar Consumption Forecast (2019-2025)
11.4 Global Infliximab and biosimilar Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Infliximab and biosimilar Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



List of Tables and Figures

Figure Picture of Infliximab and biosimilar
Table Global Infliximab and biosimilar Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Infliximab and biosimilar Production Market Share by Types in 2018
Figure Infliximab Product Picture
Table Infliximab Major Manufacturers
Figure infliximab-dyyb Product Picture
Table infliximab-dyyb Major Manufacturers
Figure infliximab-abda Product Picture
Table infliximab-abda Major Manufacturers
Table Global Infliximab and biosimilar Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Infliximab and biosimilar Consumption Market Share by Applications in 2018
Figure Crohn's Disease
Figure Pediatric Crohn's Disease
Figure Ulcerative Colitis
Figure Rheumatoid Arthritis
Figure Ankylosing Spondylitis
Figure Psoriatic Arthritis
Figure Plaque Psoriasis
Table Infliximab and biosimilar Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Infliximab and biosimilar Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Infliximab and biosimilar Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Infliximab and biosimilar Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Infliximab and biosimilar Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Infliximab and biosimilar Revenue (Million USD) (2014-2025)
Figure Global Infliximab and biosimilar Production (K Units) (2014-2025)
Table Global Infliximab and biosimilar Production (K Units) of Key Manufacturers (2014-2019)
Table Global Infliximab and biosimilar Production Share by Manufacturers (2014-2019)
Figure Infliximab and biosimilar Production Share by Manufacturers in 2018
Table Global Infliximab and biosimilar Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Infliximab and biosimilar Revenue Share by Manufacturers (2014-2019)
Figure Global Infliximab and biosimilar Revenue Share by Manufacturers in 2018
Table Global Market Infliximab and biosimilar Average Price (USD/Unit) of Key Manufacturers (2014-2019)
Figure Global Market Infliximab and biosimilar Average Price (USD/Unit) of Key Manufacturers in 2018
Table Manufacturers Infliximab and biosimilar Production Sites and Area Served
Table Manufacturers Infliximab and biosimilar Product Types
Figure Infliximab and biosimilar Market Share of Top 5 Manufacturers
Figure Infliximab and biosimilar Market Share of Top 10 Manufacturers
Table Global Infliximab and biosimilar Production (K Units) by Region (2014-2019)
Table Global Infliximab and biosimilar Production Market Share by Region (2014-2019)
Figure Global Infliximab and biosimilar Production Market Share by Region (2014-2019)
Figure Global Infliximab and biosimilar Production Market Share by Region in 2018
Table Global Infliximab and biosimilar Revenue (Million USD) by Region (2014-2019)
Table Global Infliximab and biosimilar Revenue Market Share by Region (2014-2019)
Figure Global Infliximab and biosimilar Revenue Market Share by Region (2014-2019)
Figure Global Infliximab and biosimilar Revenue Market Share by Region in 2018
Figure Global Infliximab and biosimilar Production (K Units) Growth Rate (2014-2019)
Table Global Infliximab and biosimilar Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure North America Infliximab and biosimilar Production (K Units) Growth Rate (2014-2019)
Table North America Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Europe Infliximab and biosimilar Production (K Units) Growth Rate (2014-2019)
Table Europe Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure China Infliximab and biosimilar Production (K Units) Growth Rate (2014-2019)
Table China Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Japan Infliximab and biosimilar Production (K Units) Growth Rate (2014-2019)
Table Japan Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Global Infliximab and biosimilar Consumption (K Units) Market by Region (2014-2019)
Table Global Infliximab and biosimilar Consumption Market Share by Region (2014-2019)
Figure Global Infliximab and biosimilar Consumption Market Share by Region (2014-2019)
Figure Global Infliximab and biosimilar Consumption Market Share by Region in 2018
Figure North America Infliximab and biosimilar Consumption Growth Rate (2014-2019) (K Units)
Figure Europe Infliximab and biosimilar Consumption Growth Rate (2014-2019) (K Units)
Figure China Infliximab and biosimilar Consumption Growth Rate (2014-2019) (K Units)
Figure Japan Infliximab and biosimilar Consumption Growth Rate (2014-2019) (K Units)
Table Global Infliximab and biosimilar Production (K Units) by Type (2014-2019)
Table Global Infliximab and biosimilar Production Share by Type (2014-2019)
Figure Production Market Share of Infliximab and biosimilar by Type (2014-2019)
Figure Production Market Share of Infliximab and biosimilar by Type in 2018
Table Global Infliximab and biosimilar Revenue (Million USD) by Type (2014-2019)
Table Global Infliximab and biosimilar Revenue Share by Type (2014-2019)
Figure Revenue Share of Infliximab and biosimilar by Type (2014-2019)
Figure Revenue Market Share of Infliximab and biosimilar by Type in 2018
Table Global Infliximab and biosimilar Price (USD/Unit) by Type (2014-2019)
Figure Global Infliximab and biosimilar Production Growth by Type (2014-2019) (K Units)
Table Global Infliximab and biosimilar Consumption (K Units) by Application (2014-2019)
Table Global Infliximab and biosimilar Consumption Market Share by Application (2014-2019)
Figure Global Infliximab and biosimilar Consumption Market Share by Applications (2014-2019)
Figure Global Infliximab and biosimilar Consumption Market Share by Application in 2018
Table Global Infliximab and biosimilar Consumption Growth Rate by Application (2014-2019)
Figure Global Infliximab and biosimilar Consumption Growth Rate by Application (2014-2019)
Table Janssen Biotech Infliximab and biosimilar Production Sites and Area Served
Table Janssen Biotech Product Introduction, Application and Specification
Table Janssen Biotech Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Janssen Biotech Infliximab and biosimilar Production Growth Rate (2014-2019)
Figure Janssen Biotech Infliximab and biosimilar Production Market Share (2014-2019)
Figure Janssen Biotech Infliximab and biosimilar Revenue Market Share (2014-2019)
Table Janssen Biotech Main Business and Markets Served
Table Merck and Co. Infliximab and biosimilar Production Sites and Area Served
Table Merck and Co. Product Introduction, Application and Specification
Table Merck and Co. Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Merck and Co. Infliximab and biosimilar Production Growth Rate (2014-2019)
Figure Merck and Co. Infliximab and biosimilar Production Market Share (2014-2019)
Figure Merck and Co. Infliximab and biosimilar Revenue Market Share (2014-2019)
Table Merck and Co. Main Business and Markets Served
Table Pfizer Infliximab and biosimilar Production Sites and Area Served
Table Pfizer Product Introduction, Application and Specification
Table Pfizer Infliximab and biosimilar Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Infliximab and biosimilar Production Growth Rate (2014-2019)
Figure Pfizer Infliximab and biosimilar Production Market Share (2014-2019)
Figure Pfizer Infliximab and biosimilar Revenue Market Share (2014-2019)
Table Pfizer Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Infliximab and biosimilar
Figure Manufacturing Process Analysis of Infliximab and biosimilar
Figure Infliximab and biosimilar Industrial Chain Analysis
Table Infliximab and biosimilar Distributors List
Table Infliximab and biosimilar Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Infliximab and biosimilar Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Infliximab and biosimilar Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Infliximab and biosimilar Price and Trend Forecast (2019-2025)
Table Global Infliximab and biosimilar Production (K Units) Forecast by Region (2019-2025)
Figure Global Infliximab and biosimilar Production Market Share Forecast by Region (2019-2025)
Figure North America Infliximab and biosimilar Production (K Units) and Growth Rate Forecast (2019-2025)
Figure North America Infliximab and biosimilar Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Infliximab and biosimilar Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Infliximab and biosimilar Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Infliximab and biosimilar Production (K Units) and Growth Rate Forecast (2019-2025)
Figure China Infliximab and biosimilar Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Infliximab and biosimilar Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Infliximab and biosimilar Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Infliximab and biosimilar Consumption (K Units) Forecast by Regions (2019-2025)
Figure Global Infliximab and biosimilar Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Infliximab and biosimilar Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure Europe Infliximab and biosimilar Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure China Infliximab and biosimilar Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure Japan Infliximab and biosimilar Consumption (K Units) Growth Rate Forecast (2019-2025)
Table Global Infliximab and biosimilar Production (K Units) Forecast by Type (2019-2025)
Figure Global Infliximab and biosimilar Production (K Units) Forecast by Type (2019-2025)
Table Global Infliximab and biosimilar Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Infliximab and biosimilar Revenue Market Share Forecast by Type (2019-2025)
Table Global Infliximab and biosimilar Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Infliximab and biosimilar Consumption (K Units) Forecast by Application (2019-2025)
Figure Global Infliximab and biosimilar Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Enquiry Before Buying

Report's Licence Type

$ 2900
$ 5800